Highlights Underlying Group sales growth2 of 3% for the full year, excluding OPM3 and the Strategic Review4 businesses.Group adjusted operating profit of £595-600m at £:$ of 1.28 for the full year, up ...
UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of ...